<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02411474</url>
  </required_header>
  <id_info>
    <org_study_id>4-2014-0008</org_study_id>
    <nct_id>NCT02411474</nct_id>
  </id_info>
  <brief_title>Tear Cytokine Analysis as a Prediction or Diagnostic Marker in Ocular GvHD</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigate the profiles of tear cytokines in patients who underwent stem cell
      transplantation (SCT) and attempted to determine the applicability of tear cytokines in the
      diagnosis of chronic graft-versus-host disease (GVHD). Evaluate tear cytokines as biomarkers
      of chronic ocular GVHD severity.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Actual">August 2014</completion_date>
  <primary_completion_date type="Actual">August 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>tear cytokine</measure>
    <time_frame>3-12 month after SCT</time_frame>
    <description>comparison of tear cytokines (IL-2,4,10,17a, INF-r, TNF-a) concentrations in patients with or without newly diagnosed chronic GVHD after SCT using a multiplex immunobead assay</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ocular surface status</measure>
    <time_frame>3-12 month after SCT</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>tear film break-up time</measure>
    <time_frame>3-12 month after SCT</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>conjunctival injection</measure>
    <time_frame>3-12 month after SCT</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Schirmer's test I</measure>
    <time_frame>3-12 month after SCT</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>ocular surface disease index</measure>
    <time_frame>3-12 month after SCT</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">21</enrollment>
  <condition>Chronic Graft-versus-host Disease</condition>
  <arm_group>
    <arm_group_label>With or without newly diagnosed chronic GVHD after SCT</arm_group_label>
    <description>The patients developed chronic GVHD after SCT/ The patients did not developed chronic GVHD after SCT</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      TEAR
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Male or non-pregnant female patients aged 20-60 years who visited the clinic 3-12 months
        after SCT were included in the study.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patients patients aged 20-60 years who visited the clinic 3-12 months after SCT
             were included in the study.

        Exclusion Criteria:

          -  The patients with histories of ocular surgery; ocular injury; and ocular diseases such
             as ocular infection, allergy, and autoimmune disease, as well as patients with
             long-term use of topical ocular medications except artificial tears.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Ophthalmology</name>
      <address>
        <city>Seoul</city>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Fraser CJ, Bhatia S, Ness K, Carter A, Francisco L, Arora M, Parker P, Forman S, Weisdorf D, Gurney JG, Baker KS. Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study. Blood. 2006 Oct 15;108(8):2867-73. Epub 2006 Jun 20.</citation>
    <PMID>16788100</PMID>
  </reference>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 5, 2015</study_first_submitted>
  <study_first_submitted_qc>April 2, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 8, 2015</study_first_posted>
  <last_update_submitted>April 2, 2015</last_update_submitted>
  <last_update_submitted_qc>April 2, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 8, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>stem cell transplantation (SCT)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Graft vs Host Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

